These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25061263)

  • 1. Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi.
    Araújo AF; de Oliveira G; Vasconcelos JF; Ersching J; Dominguez MR; Vasconcelos JR; Machado AV; Gazzinelli RT; Bruna-Romero O; Soares MB; Rodrigues MM
    Mediators Inflamm; 2014; 2014():605023. PubMed ID: 25061263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
    Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N; Tarleton RL
    Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
    Pereira-Chioccola VL; Costa F; Ribeirão M; Soares IS; Arena F; Schenkman S; Rodrigues MM
    Parasite Immunol; 1999 Feb; 21(2):103-10. PubMed ID: 10101720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain.
    Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM
    Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
    Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
    Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
    Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
    Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
    Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
    Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
    PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.
    Machado AV; Cardoso JE; Claser C; Rodrigues MM; Gazzinelli RT; Bruna-Romero O
    Hum Gene Ther; 2006 Sep; 17(9):898-908. PubMed ID: 16972758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.
    Giddings OK; Eickhoff CS; Sullivan NL; Hoft DF
    Infect Immun; 2010 Mar; 78(3):1333-8. PubMed ID: 20048046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.